Olusesan Ojo

Olusesan Ojo

Auto-generated profile, based on publicly available information

Olusesan Ojo

Department of Agriculture and Animal Health, University of South Africa, Johannesburg, South Africa

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Arabian Journal of Chemistry
Verified
Journal Article
Open access
MKMichael H.K. Kamdem
Michael H.K. Kamdem
OOOlusesan Ojo
Olusesan Ojo
BKBlondelle M. Kemkuignou
Blondelle M. Kemkuignou
RTRostan M. Talla
Rostan M. Talla
TFThierry Y. Fonkui
Thierry Y. Fonkui
DNDerek T. Ndinteh
Derek T. Ndinteh

28 February 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
OOOlusesan Ojo
Olusesan Ojo
MMMokgadi P. Mphahlele
Mokgadi P. Mphahlele
OOOlatunde S. Oladeji
Olatunde S. Oladeji
EMEdwin M. Mmutlane
Edwin M. Mmutlane
DNDerek Tantoh Ndinteh
Derek Tantoh Ndinteh

18 March 2025 in Natural Products and Bioprospecting
Verified
Journal Article
Open access
PDF file
OOOlusesan Ojo
Olusesan Ojo
INIdris Njanje
Idris Njanje
DADele Abdissa
Dele Abdissa
TSTarryn Swart
Tarryn Swart
RHRoxanne L. Higgitt
Roxanne L. Higgitt
RDRosemary Dorrington
Rosemary Dorrington
The rapid emergence of drug-resistant microbial pathogens has posed challenges to global health in the twenty-first century. This development has significantly made most antibiotics ineffective in the treatment of infections they cause, resulting in increasing treatment costs and annual death rates. To address the challenge posed by these pathogens, we explore the potential of secondary metabolites from Aspergillus species as a source of new and effective therapeutic agents to treat drug-resistant infections. Terpenoids, a distinct group of natural products, are extensively distributed in plants and fungi, and have been attributed with significant antibacterial, anticancer, and antiviral activities. In this review, we present an overview of Aspergillus species, and review the novel terpenoids isolated from them from 2019 to April 2024, highlighting anti-infective activity against members of the ESKAPE pathogens. We further focus on the strategies through which the structural framework of these new terpenoids could be modified and/or optimized to feed a pipeline of new lead compounds targeting microbial pathogens. Overall, this review provides insight into the therapeutic applications of terpenoids sourced from Aspergillus species and the potential for the discovery of new compounds from these fungi to combat antimicrobial resistance. Graphical Abstract

1 April 2021 in Physical Sciences Reviews
Verified
Journal Article
Closed access
OOOlusesan Ojo
Olusesan Ojo
DNDerek Tantoh Ndinteh
Derek Tantoh Ndinteh
Medicinal plants are indispensable source of therapeutic agents, and have proved to be “warehouse” of lead drug candidates.Lecaniodiscus cupanioidesPlanch. ex Benth is a medicinal tree plant that is extensively distributed in both Asia and Africa. The species has many ethnomedicinal uses in the treatment of fever, cough, typhoid, wound, skin infection, measles, jaundice, diabetes, sexual dysfunction, cancer, bone fracture, and as galactogogues. In the recent decades, the extracts and phytochemicals ofL. cupanioideshave been investigated to possess antibacterial, anticancer, aphrodisiac, antifungal, cytotoxic, antidiabetic, antiprotozoal, antioxidant, antidiarrhoeal, analgesic and ameliorative properties. However, triterpenoids which have been linked to its anticancer and antifungal actions, are the only isolated active constituents identified from the species despite the results of the phytochemical screenings and reported biological activities. Moreover, the mechanisms of action of the extracts and active components are yet to be fully elucidated. This paper provides a general review on the ethnomedicinal, phytochemicals, and biological activities ofL. cupanioides, and lays a solid foundation for future investigations on the plant.

29 May 2024 in Annales Pharmaceutiques Françaises
Verified
Journal Article
Closed access
OOOlusesan Ojo
Olusesan Ojo
RORuth Etiosa Olusola
Ruth Etiosa Olusola
OOOluwabukola Oluwafunmilayo Ojo
Oluwabukola Oluwafunmilayo Ojo

27 June 2024 in Journal of Herbmed Pharmacology
Verified
Journal Article
Open access
PDF file
OOOlusesan Ojo
Olusesan Ojo
MKMichael H.K. Kamdem
Michael H.K. Kamdem
EMEdwin M. Mmutlane
Edwin M. Mmutlane
DNDerek Tantoh Ndinteh
Derek Tantoh Ndinteh
Introduction: Mycobacterial infections remain a global problem that demands an urgent solution. Lecaniodiscus cupanioides Planch. ex Benth. is traditionally used as a medicinal plant to treat coughs, skin infections, cancers, sexual dysfunction, and malaria. This study focused on the antimycobacterial activity, cytotoxicity, and isolation of bioactive constituents of L. cupanioides chloroform leaves extract. Methods: Antimycobacterial activity was assessed using the micro-dilution assay. Cytotoxic activity of the plant was evaluated using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) assay. Column chromatography was used to purify the extract. Results: Phytochemical investigation of L. cupanioides resulted in the isolation of three compounds, including eicosene (1), nonadecanol (2), and stigmasterol (3). The isolates 1-3 as well as the column fractions displayed antimycobacterial activity, with minimum inhibitory concentration (MIC) ranging from 0.50 to 1.0 mg/mL. The studied extract, column fractions, and isolated compounds exhibited no cytotoxicity against the human cervical cancer (HeLa) cell line. Conclusion: The current results indicate that L. cupanioides has the potential to be employed in the formulation of herbal products or the development of new drugs against mycobacterial infections. However, more studies should be carried out using normal human cell lines to further unravel plant safety.